Background: Breast cancer continues to pose a significant global health challenge, demanding innovative strategies to address its multifaceted nature. This research delves into the therapeutic potential of phytocompounds extracted from Laurus nobilis, commonly known as bay laurel, with a focus on their interaction with the pivotal BRCA1 and BRCA2 proteins, well-recognized for their involvement in breast cancer pathogenesis. Methods: Utilizing a rigorous in silico methodology, our study incorporates a multifaceted array of analytical techniques. These encompass phytochemical screening, precise liquid chromatography-mass spectrometry (LC-MS) profiling, pharmacokinetic profiling of the ligands, and molecular docking studies. The phytocompounds elucidated via LC-MS analysis underwent rigorous assessment encompassing physicochemical properties, pharmacokinetic profiles, adherence to drug-likeness criteria, and evaluation of medicinal chemistry attributes.